A citation-based method for searching scientific literature

Nao Suzuki, Norihito Yoshioka, Atsushi Uekawa, Noriomi Matsumura, Akiko Tozawa, Jyunki Koike, Ikuo Konishi, Kazushige Kiguchi, Bunpei Ishizuka. Int J Gynecol Cancer 2010
Times Cited: 9







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


POU6F1 is the transcription factor that might be involved in cell proliferation of clear cell adenocarcinoma of the ovary.
Norihito Yoshioka, Nao Suzuki, Atsushi Uekawa, Kazushige Kiguchi, Bunpei Ishizuka. Hum Cell 2009
3
66

Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.
Masashi Takano, Toru Sugiyama, Nobuo Yaegashi, Satoru Sagae, Kazuo Kuzuya, Yasuhiro Udagawa, Hiroshi Tsuda, Mitsuaki Suzuki, Junzo Kigawa, Tomoko Goto,[...]. Int J Gynecol Cancer 2010
37
22

Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
Martin Köbel, Steve E Kalloger, David G Huntsman, Jennifer L Santos, Kenneth D Swenerton, Jeffrey D Seidman, C Blake Gilks. Int J Gynecol Pathol 2010
225
22

Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
K Yamaguchi, M Mandai, T Oura, N Matsumura, J Hamanishi, T Baba, S Matsui, S K Murphy, I Konishi. Oncogene 2010
119
22

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
John K Chan, Deanna Teoh, Jessica M Hu, Jacob Y Shin, Kathryn Osann, Daniel S Kapp. Gynecol Oncol 2008
267
22

mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.
Seiji Mabuchi, Chiaki Kawase, Deborah A Altomare, Kenichirou Morishige, Kenjiro Sawada, Masami Hayashi, Masahiko Tsujimoto, Mareo Yamoto, Andres J Klein-Szanto, Russell J Schilder,[...]. Clin Cancer Res 2009
117
22

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
Akira Tsuchiya, Michiie Sakamoto, Jun Yasuda, Makoto Chuma, Tsutomu Ohta, Misao Ohki, Toshiharu Yasugi, Yuji Taketani, Setsuo Hirohashi. Am J Pathol 2003
225
22

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Dimitrios Pectasides, George Fountzilas, Gerassimos Aravantinos, Charalambos Kalofonos, Helen Efstathiou, Dimitrios Farmakis, Dimosthenes Skarlos, Nikolaos Pavlidis, Theofanis Economopoulos, Meletios A Dimopoulos. Gynecol Oncol 2006
105
22

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
Da Wei Huang, Brad T Sherman, Richard A Lempicki. Nat Protoc 2009
22

A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells.
Juan A Marchal, María C Núñez, Inés Suárez, Mónica Díaz-Gavilán, José A Gómez-Vidal, Houria Boulaiz, Fernando Rodríguez-Serrano, Miguel A Gallo, Antonio Espinosa, Antonia Aránega,[...]. Breast Cancer Res Treat 2007
15
11

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.
M Müller, S Strand, H Hug, E M Heinemann, H Walczak, W J Hofmann, W Stremmel, P H Krammer, P R Galle. J Clin Invest 1997
675
11

Growth inhibition, G(1)-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives.
Juan Antonio Marchal, Houria Boulaiz, Inés Suárez, Estrella Saniger, Joaquín Campos, Esmeralda Carrillo, José Prados, Miguel Angel Gallo, Antonio Espinosa, Antonia Aránega. Invest New Drugs 2004
35
11


NPAT expression is regulated by E2F and is essential for cell cycle progression.
Guang Gao, Adrian P Bracken, Karina Burkard, Diego Pasini, Marie Classon, Claire Attwooll, Masashi Sagara, Takashi Imai, Kristian Helin, Jiyong Zhao. Mol Cell Biol 2003
44
11

N-benzoxazol-2-yl-N'-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential.
Johann Hofmann, Johnny Easmon, Gerhard Puerstinger, Gottfried Heinisch, Marcel Jenny, Alexander A Shtil, Martin Hermann, Daniele F Condorelli, Salvatore Sciré, Giuseppe Musumarra. Invest New Drugs 2009
6
16

Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies.
Mónica Díaz-Gavilán, José A Gómez-Vidal, Fernando Rodríguez-Serrano, Juan A Marchal, Octavio Caba, Antonia Aránega, Miguel A Gallo, Antonio Espinosa, Joaquín M Campos. Bioorg Med Chem Lett 2008
18
11

Identification of two active functional domains of human adenylate kinase 5.
Nicola Solaroli, Christakis Panayiotou, Magnus Johansson, Anna Karlsson. FEBS Lett 2009
10
11


The E-screen assay: a comparison of different MCF7 cell stocks.
M Villalobos, N Olea, J A Brotons, M F Olea-Serrano, J M Ruiz de Almodovar, V Pedraza. Environ Health Perspect 1995
191
11

FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.
Greg N Brooke, Rachel L Culley, D Alwyn Dart, David J Mann, Luke Gaughan, Stuart R McCracken, Craig N Robson, Bradley Spencer-Dene, Simon C Gamble, Sue M Powell,[...]. Cancer Res 2011
48
11

Molecular analysis of two enzyme genes, HPRT1 and PRPS1, causing X-linked inborn errors of purine metabolism.
Y Yamada, K Yamada, N Nomura, A Yamano, R Kimura, S Tomida, M Naiki, N Wakamatsu. Nucleosides Nucleotides Nucleic Acids 2010
4
25

Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.
Graeme M Birdsey, Nicola H Dryden, Valerie Amsellem, Frank Gebhardt, Kapil Sahnan, Dorian O Haskard, Elisabetta Dejana, Justin C Mason, Anna M Randi. Blood 2008
175
11

The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma.
Peter G Smith, Fengfei Wang, Kathryn N Wilkinson, Kerry J Savage, Ulf Klein, Donna S Neuberg, Gideon Bollag, Margaret A Shipp, Ricardo C T Aguiar. Blood 2005
110
11

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
11

Non-steroidal anti-inflammatory drugs affect the methotrexate transport in IEC-6 cells.
Aiko Sosogi, Feng Gao, Takashi Tomimatsu, Koji Hirata, Toshiharu Horie. Life Sci 2003
7
14


Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.
Jaana M Hartikainen, Hanna Tuhkanen, Vesa Kataja, Matti Eskelinen, Matti Uusitupa, Veli-Matti Kosma, Arto Mannermaa. Clin Cancer Res 2006
35
11

Stimulation of the bradykinin B(1) receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway.
Luis Molina, Carola E Matus, Angel Astroza, Francisca Pavicic, Eugenio Tapia, Cesar Toledo, Juan A Perez, Francisco Nualart, Carlos B Gonzalez, Rafael A Burgos,[...]. Breast Cancer Res Treat 2009
47
11

Identification of trypsin-inhibitory site and structure determination of human SPINK2 serine proteinase inhibitor.
Ting Chen, Tian-Ren Lee, Wei-Guang Liang, Wun-Shaing Wayne Chang, Ping-Chiang Lyu. Proteins 2009
12
11

Rac2 expression and mutation in human brain tumors.
S-L Hwang, A-S Lieu, J-H Chang, T-S Cheng, C-Y Cheng, K-S Lee, C-L Lin, S-L Howng, Y-R Hong. Acta Neurochir (Wien) 2005
19
11

Expression of YPEL1 in pancreatic cancer cell lines and tissues.
I Abiatari, M Kiladze, V Kerkadze, H Friess, J Kleeff. Georgian Med News 2009
6
16

Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells.
A Chadderton, D J Villeneuve, S Gluck, A F Kirwan-Rhude, B R Gannon, D E Blais, A M Parissenti. Breast Cancer Res Treat 2000
34
11

Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.
G P Linette, Y Li, K Roth, S J Korsmeyer. Proc Natl Acad Sci U S A 1996
313
11

Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor.
S Confalonieri, M Quarto, G Goisis, P Nuciforo, M Donzelli, G Jodice, G Pelosi, G Viale, S Pece, P P Di Fiore. Oncogene 2009
75
11

Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha.
Claudio Hetz, Paula Bernasconi, Jill Fisher, Ann-Hwee Lee, Michael C Bassik, Bruno Antonsson, Gabriel S Brandt, Neal N Iwakoshi, Anna Schinzel, Laurie H Glimcher,[...]. Science 2006
479
11

Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing.
Jerry Zhou, Larissa Belov, Pauline Y Huang, Joo-Shik Shin, Michael J Solomon, Pierre H Chapuis, Leslie Bokey, Charles Chan, Candice Clarke, Stephen J Clarke,[...]. J Immunol Methods 2010
20
11

TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity.
Richard Tomasini, Amina Azizi Samir, Alice Carrier, Daniel Isnardon, Barbara Cecchinelli, Silvia Soddu, Bernard Malissen, Jean-Charles Dagorn, Juan L Iovanna, Nelson J Dusetti. J Biol Chem 2003
117
11


TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer.
Norikatsu Miyoshi, Hideshi Ishii, Koshi Mimori, Mitsugu Sekimoto, Yuichiro Doki, Masaki Mori. Int J Oncol 2010
16
11

Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer.
Julien Fitamant, Céline Guenebeaud, Marie-May Coissieux, Catherine Guix, Isabelle Treilleux, Jean-Yves Scoazec, Thomas Bachelot, Agnès Bernet, Patrick Mehlen. Proc Natl Acad Sci U S A 2008
156
11

MycN sensitizes neuroblastoma cells for drug-induced apoptosis.
S Fulda, W Lutz, M Schwab, K M Debatin. Oncogene 1999
115
11

Differences in mRNA and microRNA microarray expression profiles in human colon adenocarcinoma HT-29 cells treated with either Intensity-modulated Radiation Therapy (IMRT), or Conventional Radiation Therapy (RT).
Farid E Ahmed, Paul W Vos, Clark Jeffries, John E Wiley, Douglas A Weidner, Helvecio Mota, Chris Bonnerup, Claudio Sibata, Ron R Allison. Cancer Genomics Proteomics 2009
16
11


Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
N Rocks, G Paulissen, M El Hour, F Quesada, C Crahay, M Gueders, J M Foidart, A Noel, D Cataldo. Biochimie 2008
174
11


Cell-cycle targeted therapies.
Charles Swanton. Lancet Oncol 2004
195
11

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.
Sungwoo Lee, Eijiro Nakamura, Haifeng Yang, Wenyi Wei, Michelle S Linggi, Mini P Sajan, Robert V Farese, Robert S Freeman, Bruce D Carter, William G Kaelin,[...]. Cancer Cell 2005
406
11

GBP1 overexpression is associated with a paclitaxel resistance phenotype.
Zhenfeng Duan, Rosemary Foster, Katherine A Brakora, Rushdia Z Yusuf, Michael V Seiden. Cancer Chemother Pharmacol 2006
43
11

Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells.
Józefa Wesierska-Gadek, Marieta Gueorguieva, Marcel Horky. Mol Cancer Ther 2005
64
11

Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, Marc J van de Vijver, Yudong D He, Augustinus A M Hart, Mao Mao, Hans L Peterse, Karin van der Kooy, Matthew J Marton, Anke T Witteveen,[...]. Nature 2002
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.